loader
Please Wait
Applying Filters...

Seqens Seqens

X

Approved Drug Products containing 202743 listed in the FDA Orange Book. Original Data : FDA Website

Client Virtual Booth
Menu
Left Arrow
Right Arrow
Filters Filter
Cross PopUp
FILTER :

filter

01 PADAGIS ISRAEL (1)

filter

01 SPRAY, METERED;NASAL (1)

filter

01 DISCN (1)

filter

01 AZELASTINE HYDROCHLORIDE (1)

filter

01 No (1)

URL Supplier Web Content
SPRAY, METERED; NA...
0.2055MG/SPRAY
2014-05-08
202743
AZELASTINE HYDROCH...
DISCN
No
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Looking for FDA Orange Book APPLICATION 202743

Looking for FDA Orange Book APPLICATION 202743 1

19

Padagis, based in Israel, is a pharmaceutical company that stands out with its certifications from FDA.

They are recognized for Setting a smart pace for the extended Topicals Rx marketplace.

One of their notable products is AZELASTINE HYDROCHLORIDE, with a corresponding application number 202743.

Regulatory Information DISCN

With a dosage strength 0.2055MG/SPRAY

Dosage Form Route SPRAY, METERED; NASAL

Reference Listed Drug No

Approved since 2014-05-08

Post Enquiry
POST ENQUIRY